# ED90 for Hyperbaric Bupivacaine in Super Obese Parturients

> **NCT03781388** · PHASE4 · COMPLETED · sponsor: **Duke University** · enrollment: 45 (actual)

## Conditions studied

- Obesity, Morbid
- Spinal Anesthesia
- Cesarean Delivery

## Interventions

- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT03781388
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-01
- **Primary completion:** 2022-12-06
- **Final completion:** 2022-12-06
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03781388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03781388, "ED90 for Hyperbaric Bupivacaine in Super Obese Parturients". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03781388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*